Michael S. Abrams - 10 May 2021 Form 3 Insider Report for Arch Therapeutics, Inc. (ARTHQ)

Reporting relationship: CFO and Treasurer
Issuer ticker: ARTHQ
Reported as of: 10 May 2021
Net transaction value: $0
SEC form: 3
Accepted by SEC: 10 May 2021, 08:02:10 UTC
Next SEC filing: 01 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Michael S. Abrams

Key filing fact

Michael S. Abrams filed Form 3 for Arch Therapeutics, Inc. (ARTHQ) on 10 May 2021.

Key facts

This page summarizes Michael S. Abrams's Form 3 filing for Arch Therapeutics, Inc. (ARTHQ).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 May 2021, 08:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARTH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 10 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $0.1329
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

33.3% of the shares subject to the option shall vest on the one-year anniversary of the the grant date, and 1/24th of the remaining unvested shares subject to this grant shall vest commencing on each f the next twenty-four (24) monthly anniversaries thereater, subject to the Exectuive's continued service for the Company through each vesting date. In the event of a Change of Control (such as defined in the Plan), then, in any such case, 100% of the number of unvested Shares then subject to the grant shall accelerate and become vested as of the date of such event.